Surfacto removes the testing bottleneck
Advances in computation and AI are expanding the number of biological designs we can generate. But experimental testing remains constrained by throughput, cost and sample requirements.
Closing the experimental gap in the Design-Build-Test-Learn cycle
You define the biological objective and design strategy. Surfacto executes highly parallel build-and-test workflows and returns functional data for the next design cycle.
A new technology stack for biological experimentation
Proprietary chemistry
Stable picolitre reaction environments for demanding biological assays.
Microfluidic control
Precise control of millions of miniaturized biological experiments in parallel.
Data linkage
A direct link from experimental function back to the underlying biological variant.
A platform for data-intensive biological workflows
Protein Engineering
Large-scale functional testing of biological variants.
Drug Discovery
Parallel measurements of biological interactions.
Synthetic Biology
Functional characterization of engineered biological systems.
Built from research, validated in the field
Surfacto is a Max Planck spin-off from Hamburg developing droplet-based biotechnology. We build our platform in-house, combining microfluidic instrumentation with proprietary surfactant chemistry for high-throughput screening.
Dr. Jacqueline De Lora
Dr. Martin Schröter
Benedikt Eikmanns
Get in touch
Surfacto is partnering with biotech companies, research organizations and AI-native biology teams looking to run more biological experiments, faster and at lower cost.